Halo digital pathology platform enterprise software license renewal

Ended Purchase Order Awarded Last action

Contract number
75N95021P00693
Awardee
Awarding agency
Obligated
$3,930,747

Award facts

Opportunity
Contract value 100% obligated
$3,930,746.81 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
511210 Software Publishers
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
LOS RNCHS ABQ, NM 87114, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00003 $288,644
Exercise an Option P00002 $1,304,034
Exercise an Option P00001 $1,139,034
Original award $1,199,034

About this award

This is a firm fixed-price purchase order awarded by the National Institutes of Health's (NIH) National Center for Advancing Translational Sciences to Indica Labs Inc., a for-profit Subchapter S corporation. The $3,930,746.81 contract provides a 3-year enterprise software license renewal for Indica Labs' HALO digital pathology platform, including support for approximately 25,000 digital slides annually for the National Cancer Institute. This requirement was not set aside. Indica Labs is the incumbent contractor and has received numerous federal awards from agencies like the Department of Health and Human Services, Department of Veterans Affairs, Food and Drug Administration, and Department of Agriculture for HALO software licenses, maintenance, and support. The original Sources Sought notice indicated the annual value for this renewal could range from $500,000 to $1,000,000.

Quick answers

Who was awarded contract 75N95021P00693?

75N95021P00693 was awarded to Indica Labs, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 27, 2021.

How much is contract 75N95021P00693 worth?

The government has obligated $3,930,747 on 75N95021P00693.

Which agency awarded contract 75N95021P00693?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00693, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95021P00693 competed?

The extent of competition for 75N95021P00693 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award